Preclinical Characterization of (R)-3-((3S,4S)-3-fluoro-4-(4-hydroxyphenyl)piperidin-1-yl)-1-(4-methylbenzyl)pyrrolidin-2-one (BMS-986169), a Novel, Intravenous, Glutamate N-Methyl-D-Aspartate 2B Receptor Negative Allosteric Modulator with Potential in Major Depressive DisorderLinda J. Bristow, Michael Sinz, Yu-Wen Li et al.|Journal of Pharmacology and Experimental Therapeutics|2017Cited by 17
Antipsychotic AgentsJeffrey M. Brown, Michael Sinz, Jie Jack Li|Burger's Medicinal Chemistry and Drug Discovery|2010Cited by 1